On Monday, MaxCyte Inc (NASDAQ: MXCT) was 4.55% up from the session before settling in for the closing price of $1.54. A 52-week range for MXCT has been $1.26 – $5.20.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -11.37%. When this article was written, the company’s average yearly earnings per share was at -9.81%. With a float of $98.09 million, this company’s outstanding shares have now reached $106.59 million.
MaxCyte Inc (MXCT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward MaxCyte Inc stocks. The insider ownership of MaxCyte Inc is 7.99%, while institutional ownership is 73.02%. The most recent insider transaction that took place on Jun 25 ’25, was worth 22,378. In this transaction Director of this company sold 10,684 shares at a rate of $2.09, taking the stock ownership to the 39,893 shares. Before that another transaction happened on Aug 13 ’25, when Company’s CHIEF FINANCIAL OFFICER bought 50,000 for $1.29, making the entire transaction worth $64,500. This insider now owns 161,811 shares in total.
MaxCyte Inc (MXCT) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.11 earnings per share (EPS) during the time that was better than consensus figure (set at -0.12) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -9.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.02% during the next five years compared to -11.37% drop over the previous five years of trading.
MaxCyte Inc (NASDAQ: MXCT) Trading Performance Indicators
You can see what MaxCyte Inc (MXCT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 11.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.42, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of MaxCyte Inc (MXCT)
Compared to the last year’s volume of 0.77 million, its volume of 0.58 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 31.10%.
During the past 100 days, MaxCyte Inc’s (MXCT) raw stochastic average was set at 31.53%, which indicates a significant decrease from 38.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1039 in the past 14 days, which was lower than the 0.1043 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5464, while its 200-day Moving Average is $2.4582. Nevertheless, the first resistance level for the watch stands at $1.6633 in the near term. At $1.7167, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.8233. If the price goes on to break the first support level at $1.5033, it is likely to go to the next support level at $1.3967. Now, if the price goes above the second support level, the third support stands at $1.3433.
MaxCyte Inc (NASDAQ: MXCT) Key Stats
There are 106,607K outstanding shares of the company, which has a market capitalization of 171.63 million. As of now, sales total 38,630 K while income totals -41,060 K. Its latest quarter income was 8,510 K while its last quarter net income were -12,360 K.
